Form 4: CareDx Executive Jeffrey Adam Novack Sells Shares Under 10b5-1 Trading Plan

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, sold 2,688 shares of common stock at $14.7 per share on May 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 5, 2025, Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., sold 2,688 shares of CareDx common stock.
• The sale was executed at a price of $14.7 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 19, 2024.
• Following the transaction, Novack directly owns 121,350 shares of CareDx common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on current inside information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

CareDx, CDNA, Jeffrey Adam Novack, Form 4, insider trading, Rule 10b5-1, stock sale, securities